Literature DB >> 17477544

An overview of pharmaceutical cocrystals as intellectual property.

Andrew V Trask1.   

Abstract

This review article focuses on the interaction among certain scientific, legal, and regulatory aspects of pharmaceutical crystal forms. The article offers an analysis of pharmaceutical cocrystals as patentable inventions by drawing upon recent scientific developments in the field. Several potential commercial advantages of pharmaceutical cocrystals are highlighted, and a number of recent court decisions involving salient issues are summarized. The article provides an outlook on how the developing field of cocrystallization may impact the pharmaceutical intellectual property landscape.

Mesh：

Substances：

Year:  2007        PMID： 17477544     DOI： 10.1021/mp070001z

Source DB:  PubMed          Journal:  Mol Pharm        ISSN： 1543-8384            Impact factor:   4.939


  19 in total

Review 1.  Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development.

Authors:  Dipak Dilip Gadade; Sanjay Sudhakar Pekamwar
Journal:  Adv Pharm Bull       Date:  2016-12-22

2.  Tunable recognition of the steroid alpha-face by adjacent pi-electron density.

Authors:  T Friscić; R W Lancaster; L Fábián; P G Karamertzanis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

3.  Hybrid nanocrystals: University of Kentucky US20060280680A1.

Authors:  Jamie E Rayahin; Jason S Buhrman; Richard A Gemeinhart
Journal:  Expert Opin Ther Pat       Date:  2012-02-25       Impact factor: 6.674

Review 4.  Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  Pharmaceutics       Date:  2018-07-31       Impact factor: 6.321

Review 5.  Remote Controlled Autonomous Microgravity Lab Platforms for Drug Research in Space.

Authors:  Shimon Amselem
Journal:  Pharm Res       Date:  2019-11-18       Impact factor: 4.200

6.  Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients.

Authors:  A V Yadav; A S Shete; A P Dabke; P V Kulkarni; S S Sakhare
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

Review 7.  Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs.

Authors:  Utsav Garg; Yasser Azim
Journal:  RSC Med Chem       Date:  2021-02-09

8.  Nifedipine-pyrazine (2/1).

Authors:  Nate Schultheiss; Melanie Roe; Jared P Smit
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-11

9.  Unexpected Salt/Cocrystal Polymorphism of the Ketoprofen-Lysine System: Discovery of a New Ketoprofen-l-Lysine Salt Polymorph with Different Physicochemical and Pharmacokinetic Properties.

Authors:  Andrea Aramini; Gianluca Bianchini; Samuele Lillini; Simone Bordignon; Mara Tomassetti; Rubina Novelli; Simone Mattioli; Larisa Lvova; Roberto Paolesse; Michele Remo Chierotti; Marcello Allegretti
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-10

Review 10.  Mechanochemistry: A Green Approach in the Preparation of Pharmaceutical Cocrystals.

Authors:  Mizraín Solares-Briones; Guadalupe Coyote-Dotor; José C Páez-Franco; Miriam R Zermeño-Ortega; Carmen Myriam de la O Contreras; Daniel Canseco-González; Alcives Avila-Sorrosa; David Morales-Morales; Juan M Germán-Acacio
Journal:  Pharmaceutics       Date:  2021-05-25       Impact factor: 6.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.